Drug · DIN 02242573
ACTOS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 30, 2018; first marketed August 28, 2000.
- Drug Identification Number (DIN)
- 02242573
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Pioglitazone A10BG03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PIOGLITAZONE (PIOGLITAZONE HYDROCHLORIDE) | 30 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 26, 2009: NOC 10716New Drug Submission (NDS) · Manufacturer name change
- May 20, 2009: NOC 10222New Drug Submission (NDS) · Manufacturer name change
- August 17, 2000: NOC 1404New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “actos”. A notice may cover another product or only some lots: read it to see what it covers.
- ACTOS (pioglitazone hydrochloride) – Potential Association with Bladder Cancer – For the PublicApril 19, 2012 · Drugs · Product safety
- ACTOS (pioglitazone hydrochloride) - Potential Association with Bladder Cancer - For Health ProfessionalsApril 19, 2012 · Drugs
Other DINs named ACTOS
- DIN 02242572 · Cancelled Post Market
- DIN 02242574 · Cancelled Post Market